Nice post Js!
Good, important point re debt free. Another factor to support a high sp once things fall into place.
Alternatively if circumstances become appropriate Corr could arrange good financing if necessary to help until sales cover us rather than a cr down the track; maybe.
On the subject of cr's I doubt we common shareholders will be involved in the next either. However if the sp is overpriced following the release of ct results, which I also doubt will occur, they might consider it wise to do a consolidation and large cr.
Your point about a licensee charging more than $300 is very interesting. Given that research indicates sufferers are willing to pay up to $1400 p.a. on products for resolution, it may be determined profits will be greater from sacrificing retail volume for a higher retail price - 600, 900, 1200. (they can't charge patients more than retail of course)
Are you becoming more confident in the value of pericoach and ALT's future?
ALT Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
